GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Teva Pharmaceutical Industries Ltd (BSP:T1EV34) » Definitions » Cyclically Adjusted FCF per Share

Teva Pharmaceutical Industries (BSP:T1EV34) Cyclically Adjusted FCF per Share : R$6.08 (As of Mar. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Teva Pharmaceutical Industries Cyclically Adjusted FCF per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Teva Pharmaceutical Industries's adjusted free cash flow per share for the three months ended in Mar. 2024 was R$-1.100. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is R$6.08 for the trailing ten years ended in Mar. 2024.

During the past 12 months, Teva Pharmaceutical Industries's average Cyclically Adjusted FCF Growth Rate was -7.80% per year. During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was -7.20% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was -8.20% per year. During the past 10 years, the average Cyclically Adjusted FCF Growth Rate was -2.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Teva Pharmaceutical Industries was 42.60% per year. The lowest was -8.60% per year. And the median was 13.35% per year.

As of today (2024-05-17), Teva Pharmaceutical Industries's current stock price is R$41.50. Teva Pharmaceutical Industries's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 was R$6.08. Teva Pharmaceutical Industries's Cyclically Adjusted Price-to-FCF of today is 6.83.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Teva Pharmaceutical Industries was 21.14. The lowest was 1.66. And the median was 4.68.


Teva Pharmaceutical Industries Cyclically Adjusted FCF per Share Historical Data

The historical data trend for Teva Pharmaceutical Industries's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Teva Pharmaceutical Industries Cyclically Adjusted FCF per Share Chart

Teva Pharmaceutical Industries Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 9.36 8.88 7.10 6.10

Teva Pharmaceutical Industries Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.93 5.97 4.82 6.10 6.08

Competitive Comparison of Teva Pharmaceutical Industries's Cyclically Adjusted FCF per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Teva Pharmaceutical Industries's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Teva Pharmaceutical Industries's Cyclically Adjusted Price-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Teva Pharmaceutical Industries's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Teva Pharmaceutical Industries's Cyclically Adjusted Price-to-FCF falls into.



Teva Pharmaceutical Industries Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Teva Pharmaceutical Industries's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2024 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-1.1/131.7762*131.7762
=-1.100

Current CPI (Mar. 2024) = 131.7762.

Teva Pharmaceutical Industries Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201406 2.246 100.560 2.943
201409 3.291 100.428 4.318
201412 4.455 99.070 5.926
201503 4.275 99.621 5.655
201506 4.749 100.684 6.216
201509 4.179 100.392 5.485
201512 6.056 99.792 7.997
201603 4.840 100.470 6.348
201606 2.932 101.688 3.800
201609 4.100 101.861 5.304
201612 -0.801 101.863 -1.036
201703 -0.203 102.862 -0.260
201706 0.784 103.349 1.000
201709 2.788 104.136 3.528
201712 1.920 104.011 2.433
201803 4.285 105.290 5.363
201806 0.096 106.317 0.119
201809 1.138 106.507 1.408
201812 0.581 105.998 0.722
201903 -0.046 107.251 -0.057
201906 -1.197 108.070 -1.460
201909 0.589 108.329 0.716
201912 1.576 108.420 1.916
202003 0.789 108.902 0.955
202006 0.670 108.767 0.812
202009 0.808 109.815 0.970
202012 0.728 109.897 0.873
202103 -2.825 111.754 -3.331
202106 0.476 114.631 0.547
202109 1.823 115.734 2.076
202112 1.555 117.630 1.742
202203 -0.926 121.301 -1.006
202206 -0.018 125.017 -0.019
202209 1.973 125.227 2.076
202212 3.916 125.222 4.121
202303 -1.327 127.348 -1.373
202306 0.888 128.729 0.909
202309 -0.627 129.860 -0.636
202312 4.663 129.419 4.748
202403 -1.100 131.776 -1.100

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.


Teva Pharmaceutical Industries  (BSP:T1EV34) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Teva Pharmaceutical Industries's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=41.50/6.08
=6.83

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Teva Pharmaceutical Industries was 21.14. The lowest was 1.66. And the median was 4.68.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Teva Pharmaceutical Industries Cyclically Adjusted FCF per Share Related Terms

Thank you for viewing the detailed overview of Teva Pharmaceutical Industries's Cyclically Adjusted FCF per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Teva Pharmaceutical Industries (BSP:T1EV34) Business Description

Address
124 Dvora HaNevi’a Street, Tel Aviv, ISR, 6944020
Teva Pharmaceutical, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the U.S. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: central nervous system with Copaxone, Ajovy and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a U.S.-based generic and specialty drug distributor.

Teva Pharmaceutical Industries (BSP:T1EV34) Headlines

No Headlines